Cancer model was developed using syngenic model of cancer studies in which three different groups of 6 animal each was made. CT26 cell lines are use for induction of tumor which was purchased from ATCC .One group contains vehicle control group and other two groups was assigned as treatment groups in which one is treated with Avastin 2mg/kg alternate day i.v. treatment for two weeks(early stage) and again for same schedule in late stage similarly other group is treated with Paclitaxel 5mg/kg i.v on alternate day treatment for 5 times (early stage) and same pattern was used for late stage schedule .The result of present study successfully provides a single model to screen anticancer compound in early stage as well as in late stage.
Loading....